What You Need to Know - Week of November 21st Nov. 22, 2022 The Lesbian, Gay, Bisexual, Transgender, Queer, and Questioning (LGBTQ+) community represents a diverse range of identities and expressions of gender and sexual orientation. In the United States, individuals who identify as lesbian, gay, and bisexual are more than twice as likely than people who identify as heterosexual to experience a mental health condition, such as depression or anxiety. Read more LGBTQ+ Mental Health Resources Nov. 22, 2022 The Lesbian, Gay, Bisexual, Transgender, Queer, and Questioning (LGBTQ+) community represents a diverse range of identities and expressions of gender and sexual orientation. In the United States, individuals who identify as lesbian, gay, and bisexual are more than twice as likely than people who identify as heterosexual to experience a mental health condition, such as depression or anxiety. Read more What You Need to Know - Week of November 14th Nov. 15, 2022 Since the more recent outbreak of monkeypox in June 2022, the virus has continued to spread throughout the world. PrEP (pre-exposure prophylaxis) can reduce your chances of getting HIV from sex or injection drug use. When taken as prescribed, PrEP reduces the risk of getting HIV from sex by about 99%. Read more Injectable Treatment for HIV Pre-Exposure Prevention Nov. 15, 2022 PrEP (pre-exposure prophylaxis) can reduce your chances of getting HIV from sex or injection drug use. When taken as prescribed, PrEP reduces the risk of getting HIV from sex by about 99%. As of 2020, more than 25% of individuals who are at risk of HIV are taking PrEP. Read more Monkeypox Update Nov. 15, 2022 Since the more recent outbreak of monkeypox in June 2022, the virus has continued to spread throughout the world. There are 28,442 confirmed cases of monkeypox in the United States, with 538 in the state of Arizona. In recent months, two monkeypox vaccines have become more accessible to the general public. Read more What You Need to Know - Week of November 7th Nov. 8, 2022 The Food and Drug Administration has approved the use of a fourth COVID-19 vaccine and booster from Novavax! A recent increase of Respiratory Syncytial Virus (RSV), a contagious respiratory virus that affects the lungs and breathing passages, among young children in the United States has sparked a discussion about the possibility of RSV, COVID-19, and influenza to create a ‘tripledemic’ this winter. Read more RSV and the 'tripledemic' Nov. 8, 2022 A recent increase of Respiratory Syncytial Virus (RSV), a contagious respiratory virus that affects the lungs and breathing passages, among young children in the United States has sparked a discussion about the possibility of RSV, COVID-19, and influenza to create a ‘tripledemic’ this winter. Although vaccines are available for COVID-19 and the Influenza virus, there are no vaccines available for RSV, making preventative measures essential to decreasing the spread of RSV. Read more Novavax COVID-19 Vaccine and Booster Nov. 8, 2022 The Food and Drug Administration has approved the use of a fourth COVID-19 vaccine and booster from Novavax! The Novavax vaccine is 90% effective against mild to moderate cases of COVID-19. Using a traditional protein-based vaccine that uses only part of the virus that is delivered directly to the cells, Novavax differs from the mRNA approach taken by Pfizer-BioNTech, Moderna, and Johnson and Johnson. Read more Image What You Need to Know - Week of October 31st Nov. 1, 2022 Happy National Native American Heritage Month! Since 1986, the United States has honored over 12,000 years of Native American history, culture, and art every year in November. This month provides a time to reflect, educate, and expand your knowledge of Native American culture. Public Health Emergency was initially announced in January 2020 in response to the global COVID-19 outbreak. The Public Health Emergency allows for new healthcare policies to help individuals be resilient throughout a time of uncertainty. Read more Extension of the Public Health Emergency Nov. 1, 2022 A Public Health Emergency was initially announced in January 2020 in response to the global COVID-19 outbreak. The Public Health Emergency allows for new healthcare policies to help individuals be resilient throughout a time of uncertainty. Although there has been a decrease in the number of confirmed COVID-19 cases in the United States, the government has again extended the Public Health Emergency through January 2023, when it will be reevaluated and potentially extended for an additional 90 days. We’ve answered some questions about the recent renewal, and what will happen when the Public Health Emergency ends: Read more Pagination « First First page ‹ Previous Previous page … 1 2 3 4 5 6 7 8 9 … Next › Next page Last » Last page
What You Need to Know - Week of November 21st Nov. 22, 2022 The Lesbian, Gay, Bisexual, Transgender, Queer, and Questioning (LGBTQ+) community represents a diverse range of identities and expressions of gender and sexual orientation. In the United States, individuals who identify as lesbian, gay, and bisexual are more than twice as likely than people who identify as heterosexual to experience a mental health condition, such as depression or anxiety. Read more
LGBTQ+ Mental Health Resources Nov. 22, 2022 The Lesbian, Gay, Bisexual, Transgender, Queer, and Questioning (LGBTQ+) community represents a diverse range of identities and expressions of gender and sexual orientation. In the United States, individuals who identify as lesbian, gay, and bisexual are more than twice as likely than people who identify as heterosexual to experience a mental health condition, such as depression or anxiety. Read more
What You Need to Know - Week of November 14th Nov. 15, 2022 Since the more recent outbreak of monkeypox in June 2022, the virus has continued to spread throughout the world. PrEP (pre-exposure prophylaxis) can reduce your chances of getting HIV from sex or injection drug use. When taken as prescribed, PrEP reduces the risk of getting HIV from sex by about 99%. Read more
Injectable Treatment for HIV Pre-Exposure Prevention Nov. 15, 2022 PrEP (pre-exposure prophylaxis) can reduce your chances of getting HIV from sex or injection drug use. When taken as prescribed, PrEP reduces the risk of getting HIV from sex by about 99%. As of 2020, more than 25% of individuals who are at risk of HIV are taking PrEP. Read more
Monkeypox Update Nov. 15, 2022 Since the more recent outbreak of monkeypox in June 2022, the virus has continued to spread throughout the world. There are 28,442 confirmed cases of monkeypox in the United States, with 538 in the state of Arizona. In recent months, two monkeypox vaccines have become more accessible to the general public. Read more
What You Need to Know - Week of November 7th Nov. 8, 2022 The Food and Drug Administration has approved the use of a fourth COVID-19 vaccine and booster from Novavax! A recent increase of Respiratory Syncytial Virus (RSV), a contagious respiratory virus that affects the lungs and breathing passages, among young children in the United States has sparked a discussion about the possibility of RSV, COVID-19, and influenza to create a ‘tripledemic’ this winter. Read more
RSV and the 'tripledemic' Nov. 8, 2022 A recent increase of Respiratory Syncytial Virus (RSV), a contagious respiratory virus that affects the lungs and breathing passages, among young children in the United States has sparked a discussion about the possibility of RSV, COVID-19, and influenza to create a ‘tripledemic’ this winter. Although vaccines are available for COVID-19 and the Influenza virus, there are no vaccines available for RSV, making preventative measures essential to decreasing the spread of RSV. Read more
Novavax COVID-19 Vaccine and Booster Nov. 8, 2022 The Food and Drug Administration has approved the use of a fourth COVID-19 vaccine and booster from Novavax! The Novavax vaccine is 90% effective against mild to moderate cases of COVID-19. Using a traditional protein-based vaccine that uses only part of the virus that is delivered directly to the cells, Novavax differs from the mRNA approach taken by Pfizer-BioNTech, Moderna, and Johnson and Johnson. Read more
Image What You Need to Know - Week of October 31st Nov. 1, 2022 Happy National Native American Heritage Month! Since 1986, the United States has honored over 12,000 years of Native American history, culture, and art every year in November. This month provides a time to reflect, educate, and expand your knowledge of Native American culture. Public Health Emergency was initially announced in January 2020 in response to the global COVID-19 outbreak. The Public Health Emergency allows for new healthcare policies to help individuals be resilient throughout a time of uncertainty. Read more
Extension of the Public Health Emergency Nov. 1, 2022 A Public Health Emergency was initially announced in January 2020 in response to the global COVID-19 outbreak. The Public Health Emergency allows for new healthcare policies to help individuals be resilient throughout a time of uncertainty. Although there has been a decrease in the number of confirmed COVID-19 cases in the United States, the government has again extended the Public Health Emergency through January 2023, when it will be reevaluated and potentially extended for an additional 90 days. We’ve answered some questions about the recent renewal, and what will happen when the Public Health Emergency ends: Read more